AgeX Therapeutics
AgeX Therapeutics is a pluripotent stem cell-derived progenitor cell lines founded in 2017 by Michael D. West.
6
Funding Rounds
$163.8m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** D We** | - | - | |
| Mi***** D. We** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Mi***** D. We** | - | - | |
| Mi***** Ma* | - | - |
Funding series
Funding Series Analysis
The company AgeX Therapeutics has raised a total of $100m in funding over 6 rounds.
Key Insights:
- AgeX , August 2017: $100m
- AgeX Therapeutics Private equity, September 2018: $43.2m
- AgeX Therapeutics Venture round, August 2018: $5.2m
- AgeX Therapeutics Private equity, June 2018: $5m
- AgeX Therapeutics Grant (money), May 2018: $386k
- AgeX Therapeutics Venture round, August 2017: $10m
AgeX , August 2017
$100m
AgeX Therapeutics Private equity, September 2018
$43.2m
AgeX Therapeutics Venture round, August 2018
$5.2m
AgeX Therapeutics Private equity, June 2018
$5m
AgeX Therapeutics Grant (money), May 2018
$386k
AgeX Therapeutics Venture round, August 2017
$10m
Industries
AgeX Therapeutics is active in the following industries: